ElintMAX Respiratory Monitor (ElintMAX Monitor A1)
Amptron Medical, Inc. · Decision date Sep 16, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-16 for K260226, submitted by Amptron Medical, Inc. of Carlsbad, California, for the ElintMAX Respiratory Monitor (ElintMAX Monitor A1). The device falls under regulation 868.1850, classification product code BZK, with subsequent product code BZQ, and the regulation medical specialty and 510(k) review panel are both anesthesiology. The submission was a traditional 510(k) received on 01/26/2026, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan. SESE means clearance to market, not PMA approval.
The public record does not describe the device's components, its specific indications for use, or the predicate device relied upon, and no summary statement is present in the retrieved data. The TPLC listing associates Amptron Medical with regulation 868.1850 and the K260226 record, but its excerpts are fragmentary and do not add substantive detail about the cleared device. Any comparison to another cleared respiratory monitor, or any claim about clinical performance, would require the underlying FDA documents rather than this database entry.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Sep 16, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260226
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Amptron Medical, Inc.
- Product code
- BZK
- Decision code
- SESE
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Spirometer, Monitoring (W/Wo Alarm).
- Applicant
- Amptron Medical, Inc.
- Product code
- BZK
- FDA device class
- 2
FDA decision timeline
K260226 received
Application receipt date recorded by FDA.
K260226 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Amptron Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Carlsbad, CA
Sources and methodology
- Original FDA record: K260226
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records